Oklahoma Administrative Code
Title 310 - Oklahoma State Department of Health
Chapter 566 - Comprehensive Breast and Cervical Cancer Detection and Treatment
Subchapter 1 - General Provisions
Section 310:566-1-7 - Criteria for certified screening provider

Universal Citation: OK Admin Code 310:566-1-7
Current through Vol. 42, No. 1, September 16, 2024

Physicians (M.D., D.O.), advanced practice nurses, physician assistants, and Certified Nurse Midwives who have signed a memorandum of understanding with the Oklahoma Breast and Cervical Cancer Early Detection Program can be a certified provider. The provider in signing the memorandum of understanding certifies that the woman received breast or cervix screening, was found to be in need of treatment, and meets eligibility criteria for referral to the Medicaid Breast and Cervical Cancer Treatment Program. Eligibility criteria includes that the woman is between the ages of 19 and 64, is a US Citizen or qualified alien and a resident of Oklahoma, has an income at or below 185% of the current Federal Poverty Level, has provided a social security number, does not have creditable coverage for breast or cervical cancer treatment, and has an abnormal finding following a breast or cervical cancer screening service. Suspicious findings for breast includes clinical breast exam findings of: palpable breast mass, breast dimpling, nipple retraction, bloody nipple discharge, palpable lymph nodes around clavicle or axilla, nipple erythema and scaliness, a mammography result of BiRads 4 (Suspicious Abnormality suggesting need for biopsy) or 5 (Highly Suggestive of Malignancy) (ICD 793.8), breast biopsy result of Ductal Cancer in situ, Lobular Cancer in situ (ICD 233.0), or breast or lymph node (or other) biopsy result of breast cancer. Suspicion of cervical cancer is a Pap test result of Atypical Squamous Cells (ASC), Atypical glandular cells (AGC), Low-grade squamous intraepithelial lesions (LSIL), or High-grade squamous intraepithelial lesions (HSIL) (ICD 622.1), leukoplakia of the cervix, (ICD 622.2), or cervical biopsy result of Cervical intraepithelial neoplasia II or III, or Cancer in situ (ICD 233.1). Certified screening providers need not be BCCEDP contractors, and will not be reimbursed by the BCCEDP nor by Medicaid for the screening services provided to the woman.

Added at 22 Ok Reg 400, eff 12-21-04 (emergency); Added at 22 Ok Reg 2409, eff 7-11-05

Disclaimer: These regulations may not be the most recent version. Oklahoma may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.